On November 10, advocacy organizations, researchers and patients will take a moment to recognize the tremendous progress that has been made in the study and treatment of neuroendocrine tumors (NETs) ...

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs. Jennifer Chan, MD, MPH, ...

This retrospective review demonstrates the increased use of active surveillance in patients with small nonfunctional pancreatic neuroendocrine tumors. Results from a retrospective review demonstrated ...

Neuroendocrine tumors (NETs) are a type of cancerous growth affecting cells that send hormones around the body. Pancreatic neuroendocrine tumors (PNETs) grow in the cells of the pancreas that produce ...

When Kyle Pukylo started feeling stomach pain, he struggled to find a doctor who could see him in person on short notice in Lakeland, Florida, where he lives. So he booked a telehealth session. “They ...

Patients with previously treated advanced neuroendocrine tumors who received treatment with Cabometyx had improved progression-free survival compared with placebo. Cabometyx (cabozantinib) provided a ...

The likelihood of curing tongue cancer can depend on factors such as a person’s overall health and age, the size of the tumor, and whether the cancer has spread beyond the tongue. Squamous cell ...

Getting your care team in place, relieving digestive symptoms, and maintaining healthy lifestyle habits are all great ways to prep for treatment. Pancreatic cancer doesn’t have to be a death sentence.

Biodexa Pharmaceuticals PLC is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The Company’s lead candidate, MTX110, ...

Smoking cigarettes increases your risk of cancer. Quitting smoking is your best choice for lowering your risk. We know that smoking cigarettes increases your risk of cancer. But how many years of ...

Treatment with an anti-VEGF tyrosine kinase inhibitor appears safe for patients with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors. Anti-vascular endothelial growth ...

Social media claims that research by American inventor Royal Raymond Rife in the 1920s and 1930s -- as well as modern techniques that use targeted low-frequency energy -- represent a workable cancer ...